USC Apologizes for Taking Over UCSD’s Alzheimer’s Program

The University of Southern California reaches a settlement with the University of California, San Diego, over snatching staff, data, and funding in 2015.

Written byChia-Yi Hou
| 2 min read
university of Southern California San Diego lawsuit settlement Alzheimer's Paul Aisen research group program takeover raid move

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM
WOLTERK

The University of Southern California has publicly apologized to the University of California, San Diego, for the way that it took over the Alzheimer’s Disease Cooperative Study in 2015, reports The San Diego Union-Tribune. At the time, Paul Aisen, other staff members, the program’s data, and contracts worth tens of millions of dollars were transferred to USC in a move that led to a lawsuit, according to the Union-Tribune.

The Alzheimer’s Disease Cooperative Study (ADCS) formed in 1991 by the National Institute on Aging (NIA) and the University of California, San Diego (UCSD). In 2015, USC convinced sponsors of ADCS to move their contracts to USC, according to reporting by the Union-Tribune at the time. Aisen, who joined ADCS in 2007 as the director, says UCSD did not give the program the resources that it needed, according to the Union-Tribune. “I believe the science is more important ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies